內房股集體飆升 融創中國一度漲42%創紀錄最大漲幅
格隆匯3月17日丨港股內房股集體飆升,融創中國盤中一度大漲42%,創紀錄最大漲幅。目前龍光集團、旭輝、時代中國、碧桂園、寶龍地產漲幅均超20%,新城發展漲近20%,綠景中國和龍湖集團漲超15%,中國恆大、雅居樂、合景泰富漲超13%,佳兆業集團、、世茂集團和富力地產漲超10%。消息面上,國務院金融委表示,要及時研究和提出有力有效的防範化解風險應對方案,提出向新發展模式轉型的配套措施;銀保監會表示,鼓勵機構穩妥有序開展併購貸款,重點支持優質房企兼併收購困難房企優質項目;財政部表示,今年內不具備擴大房地產税改革試點城市的條件。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.